The cardiovascular-focused pharmaceutical company has raised $94m in equity from investors including strategic partner Sanofi.

Cornell University to open cancer nanotechnology centre with Memorial Sloan Kettering, one of the three institutes behind Juno Therapeutics.

Pfizer and Bristol-Myers Squibb will buy a combined $15m of stock in the immuno-oncology drug developer through the offering.

Immuno-oncology treatment developer Corvus has boosted its total funding to more than $100m after securing funding from backers including Novo and Roche.

A round up of all the latest news on www.globalcorporateventuring.com for our subscribers.

The health information portal was reported earlier this week to have secured $300m from unnamed investors, which has now also been revealed to feature Tencent and Fosun.

Tencent previously invested $106.5m in the health information portal in October 2014.